TriSalus Life Sciences, Inc. (TLSI)
(Delayed Data from NSDQ)
$4.18 USD
-0.05 (-1.18%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $4.20 +0.02 (0.48%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
TLSI 4.18 -0.05(-1.18%)
Will TLSI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TLSI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TLSI
TriSalus Life Sciences, Inc. (TLSI) Reports Q1 Loss, Lags Revenue Estimates
OrganiGram (OGI) Reports Q2 Loss, Beats Revenue Estimates (Revised)
TLSI: What are Zacks experts saying now?
Zacks Private Portfolio Services
OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates
TerrAscend Corp. (TSNDF) Reports Q1 Loss, Lags Revenue Estimates
SurModics (SRDX) Reports Q2 Loss, Misses Revenue Estimates
Other News for TLSI
TriSalus Life Sciences to Participate in the Canaccord Genuity 45th Annual Growth Conference | ...
TriSalus Life Sciences to Host Second Quarter 2025 Financial Results Conference Call | TLSI ...
TriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent ...
TriSalus Life Sciences management to meet virtually with Lake Street
Lake Street Keeps Their Buy Rating on TriSalus Life Sciences (TLSI)